Long term outcomes in men screened for abdominal aortic aneurysm: prospective cohort study by Duncan, John L et al.
Long term outcomes in men screened for abdominal
aortic aneurysm: prospective cohort study
OPEN ACCESS
John L Duncan consultant
1, Kirsten A Harrild research fellow
2, Lisa Iversen research fellow
3, Amanda
J Lee professor
2, David J Godden professor
4
1Department of Surgery, Raigmore Hospital, Inverness IV2 3UJ, UK;
2Medical Statistics Team, Division of Applied Health Sciences, University of
Aberdeen, Aberdeen, UK;
3Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen;
4Centre for Rural Health, University
of Aberdeen, Centre for Health Sciences, Inverness
Abstract
Objective To determine whether there is a relation between aortic
diameter and morbidity and mortality in men screened for abdominal
aortic aneurysm.
Design Prospective cohort study.
Setting Highland and Western Isles (a large, sparsely populated area
of Scotland).
Participants 8146 men aged 65-74.
Main outcome measures Morbidity and mortality in relation to presence
of abdominal aortic aneurysm and three categories of aortic diameter
(≤24 mm, 25-29 mm, and ≥30 mm).
Results When screened, 414 men (5.1%) had an aneurysm (diameter
≥30 mm), 669 (8.2%) an aortic diameter of 25-29 mm, and 7063 (86.7%)
an aortic diameter of ≤24 mm. The cohort was followed up for a median
of 7.4 (interquartile range 6.9-8.2) years. Mortality was significantly
associated with aortic diameter: 512 (7.2%) men in the ≤24 mm group
died compared with 69 (10.3%) in the 25-29 mm group and 73 (17.6%)
in the ≥30 mm group. The mortality risk in men with an aneurysm or with
an aorta measuring 25-29 mm was significantly higher than in men with
an aorta of ≤24 mm. The increased mortality risk in the 25-29 mm group
was reduced when taking confounders such as smoking and known
heart disease into account. After adjustment, compared with men with
an aortic diameter of ≤24 mm, the risk of hospital admission for
cardiovascular disease and chronic obstructive pulmonary disease was
significantly higher in men with aneurysm and those with aortas
measuring 25-29 mm. Men with an aneurysm also had an increased
risk of hospital admission for cerebrovascular disease, atherosclerosis,
peripheral arterial disease, and respiratory disease. In men with aortas
measuring 25-29 mm, the risk of hospital admission with abdominal
aortic aneurysm was significantly higher than in men with an aorta of
≤24 mm (adjusted hazard ratio 6.7, 99% confidence interval 3.4 to 13.2)
and this increased risk became apparent two years after screening.
Conclusions Men with abdominal aortic aneurysm and those with aortic
diameters measuring 25-29 mm have an increased risk of mortality and
subsequent hospital admissions compared with men with an aorta
diameter of ≤24 mm. Consideration should be given to control of risk
factors and to rescreening men with aortas measuring 25-29 mm at
index scanning.
Introduction
Screening for abdominal aortic aneurysm in men over 65 years
ofagehasbeenrecommendedonthebasisofseveralrandomised
controlledtrialsandmeta-analyses.
1 2Thesestudieshaveshown
that a single screening examination using ultrasound with
follow-up intervention as appropriate can reduce aneurysm
related mortality, with benefits extending to at least 10 years.
3
Screening has been shown to be cost effective
4 and has already
been, or is being, introduced in the United Kingdom.
5 6 Patients
with an abdominal aortic aneurysm, however, have also been
shown to have an increased mortality from other vascular
disease,
4 7 8whichinsomepartmayberesponsibleforthefailure
of screening for abdominal aortic aneurysm to reduce all cause
mortality in most studies.
7
Most screening protocols use a threshold aortic diameter of 30
mm. Men with an aorta at or above this diameter are entered
into a follow-up programme and those below are reassured and
no follow-up planned. Among those without an aneurysm,
however, there is some evidence of a possible association
between aortic diameter and mortality, raising the possibility
of a significantly increased risk among those whose aortic
diameter is just below the threshold for aneurysm.
9
We used record linkage to investigate the health outcomes of a
group of 8146 men who attended the Highland aortic aneurysm
screeningprogrammebetween2001and2004andwerefollowed
until mid 2010, and to determine how these outcomes related
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RESEARCHto aortic diameter. We examined morbidity and mortality for
men who had an aortic aneurysm (aortic diameter ≥30 mm),
and those who had an ectatic aorta (25-29 mm) compared with
those whose aorta was ≤24 mm at initial screening.
Methods
Between April 2001 and March 2004 we invited men in
Highland and Western Isles aged 65-74 to attend the Highland
aorticaneurysmscreeningprogramme.Atthetimeoftheinitial
scan, men completed a questionnaire about their general health
andprovidedpersonaldetails.Theprogramme’sdatasetcontains
ageatscreening,selfratedassessmentofhealth,smokinghistory
(inpackyears),medicalhistory,familyhistoryofcardiovascular
disease and diabetes, place of birth, postcode, duration of time
living in the region, and the outcome of the abdominal aortic
aneurysm screening.
The aortic diameter was defined as the maximum
antero-posterior diameter, measured to the nearest millimetre.
Failure to image in the community was followed through with
hospital based ultrasound. We defined abdominal aortic
aneurysm as an aorta measuring 30 mm or more; men with
aortas of this size were followed up using the protocol from the
MulticentreAneurysmScreeningStudy.
10Menwithabdominal
aorticaneurysmsmeasuring30-44mmwererescannedannually
and those with aortas measuring 45-54 mm were rescanned
every three months. Men with aneurysms measuring 55 mm or
more were considered for surgery. Men with aneurysms were
offered lifestyle advice, and correspondence to their general
practitionersuggestedtreatmentwithaspirinandastatin.Those
men with a “normal” scan (aortic diameter ≤29 mm) had no
further intervention or screening.
By linking the questionnaire data from the Highland aortic
aneurysm screening programme to the Scottish Morbidity
RecordlinkeddatasetheldbytheInformationServicesDivision
attheScottishgovernmenthealthdepartmentweobtainedlonger
term outcomes (aneurysm related morbidity and mortality in
relation to aortic diameter at screening). Using probability
matching,theInformationServicesDivisionlinkedtheHighland
aortic aneurysm screening programme dataset to the national
ScottishMorbidityRecorddatabase(comprisedofgeneralacute
inpatient and day case discharges SMR01, cancer registrations
SMR06, and the General Registrar Office-Scotland death
registrations) and provided an anonymous linked dataset for
analysis. Appendix 1 shows the outcome codes (international
classificationofdiseases,ninthand10threvisions).Deprivation
wasexpressedinfifthsand10thsaccordingtotheScottishindex
ofmultipledeprivation,
11andruralitybytheScottishgovernment
urban-rural classification
12; both were derived from postcodes.
We obtained descriptive statistics for the cohort as a whole and
categorised participants by their baseline aortic diameter into
three groups: ≤24 mm, 25-29 mm, and ≥30 mm. To compare
categorical variables between the three groups we used χ
2 tests
fortrend,withanalysisofvarianceandtheKruskal-Wallistests
used to compare normally and non-normally distributed data
across the groups.
The end of follow-up was 26 June 2010. Cox proportional
hazards regression was used to calculate crude hazard ratios
(99%confidenceintervals)foreventsofinterest.Wecompared
each of the 25-29 mm and 30 mm or more groups with the 24
mm or less group. Subsequently we simultaneously adjusted
the estimates for a range of personal characteristics, indicators
ofmedicalhistory,andmarkersofgeneralhealth.Thepotential
covariates included those identified from a review of published
literature,togetherwiththosedeemedclinicallyimportantwhen
examiningtheassociationbetweenaorticdiameterandmorbidity
and mortality. Into the models we entered the number of pack
years smoked, with a value of zero for non-smokers, and
deprivation 10th, rather than fifth, but otherwise the variables
remained in their original format (categorical or continuous).
Smoking status was the only variable that was initially
considered for entry into the models but not subsequently used,
owingtocollinearitywithpackyears.Toavoidcompetingrisks,
in the survival analyses of each non-fatal event of interest we
excludedthosemenwhohadhadoneoftheotherlistednon-fatal
events. The models for mortality included all the men. For the
hospital admission outcomes we produced separate
Kaplan-Meier survival curves for each aortic diameter group.
Tests for interactions between deprivation 10th and aortic
diameter group were done for all hospital admission outcomes.
ForthoseoutcomeswithatestforinteractionP<0.10,wecarried
out further survival analyses stratified by deprivation fifth.
Theproportionofmissingvaluesamongthepersonalandhealth
related factors was low (<9%) and seemed to be missing at
random. Therefore we excluded missing values from the
analysis. Owing to multiple outcomes, we regarded a more
stringentPvalueof≤0.01asstatisticallysignificantforthemain
analyses. All analyses were carried out using the software
package PASW Statistics 18.0.2 (SPSS, Chicago, IL).
Results
Of the 8355 men who attended for screening,
13 8146 (97.5%)
completed the questionnaire and so were available for record
linkage. The uptake of screening in the original cohort was
89.6%(3.8%declinedanappointmentand6.6%didnotattend).
The figure of 8146 therefore represents 86% of the men aged
65-74 living in the region between 2001 and 2004. The median
durationoffollow-upwas7.4(interquartilerange6.9-8.2)years.
Of the 8146 men, 414 (5.1%) had an aortic aneurysm (aortic
diameter ≥30 mm), 669 (8.2%) had an aortic diameter 25-29
mm, and 7063 (86.7%) a diameter of 24 mm or less. Table 1⇓
shows the personal and health related data obtained from the
questionnaire. A larger aortic diameter at screening was
associated with older age (although the differences in age were
small); current smoking; higher pack years (among ever
smokers); poorer self assessed health; reported previous heart
attack,hypertension,orstroke;andafamilyhistoryofaneurysm.
Of the 8146 men, 654 (8.0%) died within the follow-up period.
Table 2⇓ shows the primary cause of death. Mortality was
associated with aortic diameter at screening: 512 (7.2%) men
with an aortic diameter of 24 mm or less died compared with
69 (10.3%) with a diameter of 25-29 mm and 73 (17.6%) with
a diameter of 30 mm or more. Aneurysm accounted for only 11
deaths(1.7%ofalldeaths).Ofthenineaneurysmrelateddeaths
in men with an initial aortic diameter of 30 mm or more, five
were caused by ruptured abdominal aortic aneurysm and the
rest were postoperative deaths. Deaths in only two men with an
aortic diameter less than 30 mm were attributed to aneurysm
during follow-up, neither associated with rupture. Most of the
excess mortality risk associated with aortic diameter was due
to hypertension and vascular disease or cancer, relations that
persisted in the 30 mm or more group even after adjustment for
potential confounders. Men with an aortic diameter of 30 mm
or more were over three times as likely to die from cancer
(adjusted hazard ratio 3.03, 99% confidence interval 1.41 to
6.53) and nearly twice as likely to die from hypertensive and
vascular disease (1.90, 1.17 to 3.08) than men with an aortic
diameter of 24 mm or less.
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RESEARCHAortic diameter at screening was also associated with hospital
admissions(table3⇓).Theproportionofmenwithnosubsequent
hospital admission was 34.8% (n=2459) in the 24 mm or less
group compared with 29.6% (n=198) in the 25-29 mm group
and16.9%(n=70)inthe30mmormoregroup.Increasingaortic
diameteratscreeningwasassociatedwithincreasedsubsequent
risk of admission for all circulatory disease (table 3 and fig 1⇓).
After adjustment for potential confounders, men with aortic
diameters or more than 25 mm were at increased risk of
hypertensive disease, ischaemic heart disease, and chronic
obstructive pulmonary disease, whereas the increased risk of
cerebrovascular disease, atherosclerosis, peripheral arterial
disease, and diseases of the respiratory system was significant
only in the 30 mm or more group. Compared with men with an
aortic diameter of 24 mm or less, those with an aortic diameter
of 25-29 mm had an increased risk of diabetes mellitus and of
heart failure, but these risks were not found in men with an
aneurysm.Lungcancerremainedmorecommonintheaneurysm
group after adjustment. Men with an aneurysm at screening
wereoverseventimesmorelikelytohaveabdominalwallhernia
or conditions such as intraperitoneal adhesions (table 3).
Increasing aortic diameter at screening was associated with
increasingriskofsubsequentadmissionforaneurysm.Forthose
in the 25-29 mm category, this became evident from two years
after screening (fig 2⇓).
Discussion
In this study, baseline screening identified 5.1% of men with
an aneurysm (≥30 mm) and 8.2% with an aortic diameter of
25-29 mm, which has been termed ectatic aorta. A previous
study found a prevalence of 7.5% of ectatic aorta in a similar
aged cohort using similar criteria for diameter, but included a
distal renal/aortic antero-posterior diameter ratio of more than
1.2 as an alternative definition.
14 A key issue dealt with by our
study is whether men with an ectatic aorta have an excess risk
of poor outcomes. The mortality rate in our cohort during
follow-up was low and deaths due to aneurysm were rare.
However,increasingaorticdiameteratscreeningwasassociated
with increased mortality from vascular disease or cancer and
increased risk of hospital admissions, mainly related to
circulatoryandrespiratorydiseasesandcertainformsofcancer.
Theincreasedmorbiditywasnotednotonlyinthosewithaortic
aneurysmatinitialscreeningbutalsointhosewithectaticaortas,
asmallproportionofwhomwerealsodischargedfromhospital
withadiagnosisofaneurysmduringfollow-up.Theserelations
held after adjustment for several potential confounders.
Comparison with other studies
Mortalityinthiscohort—8%afteramedianof7.4(interquartile
range 6.9-8.2) years follow-up—was low compared with
previously published series. In the Multicentre Aneurysm
Screening Study cohort, who were of similar age to ours,
mortality in the invited group was 11.4% after a median
follow-upof4.1years
10andtotalmortalitywas30%at10years.
3
IntheTromsostudy,
15whichincludedawideragerangeofmen
and women (25-84 years), mortality in men at 10 years was
19.9%,andintheAmericanCardiovascularHealthstudy,which
included men and women with an average age of 75 at
screening,
9 mortality at 10 years was 38.6%. The reasons for
our lower mortality, apart from differences in age, are unclear,
although may reflect improving cardiovascular risk prevention
andtherelativelyruralnatureofourcohort.
13 16Theriskofdeath
from aneurysm in our cohort was low. In total, 11 deaths were
reported as being due to aneurysm, representing 0.14% of the
cohortand1.7%ofalldeaths.Mostofthesedeathswereinmen
whohadaneurysmatinitialscreening.Onlytwodeathsoccurred
among those with an aortic diameter of less than 30 mm,
representing 0.03% of that group. In the Multicentre Aneurysm
Screening Study, the death rate from aneurysm at 10 years
among those who attended screening was 0.33% (91/27 201),
whereas 19 deaths (0.08%) were reported in 25 541 men with
an index scan showing an aortic diameter of less than 30 mm.
The follow-up was 10.1 years, making the risk of a ruptured
aneurysm1:10216lifeyearscomparedwith1:12454lifeyears
for this study. In the Multicentre Aneurysm Screening Study
cohort, however, the rate of rupture increased noticeably in
years 8-10 of follow-up. In the Tromso study,
15 the death rate
from aneurysm for the whole cohort at 10 years was 0.41%
(27/6640), whereas for those with normal scans it was 0.1%
(7/6295).
Although the risk of aneurysm related mortality is small,
previous studies have shown a significant risk of developing an
aneurysm in men with an aortic diameter of 25-29 mm.
14 17 One
study, in a UK programme, found an expansion rate of 0.9 mm
yearlyinmenwithectaticaortas,resultingin2.4%ofthesemen
exceeding an aortic diameter of 55 mm or requiring surgery
within five years of initial screening.
17 A Danish study found
that 29% of men with an initial aortic diameter of 25-29 mm
went on to develop aneurysms, with expansion rates varying
from 1-4.7 mm annually.
14 Both studies concluded that men
with ectatic aortas should be screened every five years. In our
study, men whose initial aortic diameter was less than 30 mm
were not rescanned, so we cannot report rates of expansion or
the development of aneurysm. However, 4.5% of men with an
aortic diameter of 25-29 mm had a hospital admission with an
aneurysm diagnosis during follow-up, such presentations
becomingnoticeablefromtwoyearsafterscreening,supporting
the concept of repeat screening in the 25-29 mm group. The
association between aneurysm and cardiovascular disease that
we observed has been shown in several studies.
16 18 19 In the
Tromso study,
15 an abdominal aortic aneurysm at baseline
conferred a 2.5-fold increase in cardiovascular mortality over
10years,comparedwitha1.88-foldincreasedriskinourstudy.
One study followed up 4734 men and women aged over 65 for
10 years.
9 They found an increased risk of mortality associated
with aneurysm, but the increased risk of cardiovascular events
in men with aortic diameters of 20-29 mm did not reach
statistical significance. However, the criteria for a diagnosis of
abdominal aortic aneurysm and the follow-up periods differed
betweenthestudies.TheUKSmallAneurysmTrialalsoshowed
that aortic aneurysm was a marker for cardiovascular disease,
with increased cardiovascular mortality not related to
aneurysm.
20
Men with abdominal aortic aneurysm therefore have an
increased risk of cardiovascular disease, suggesting that
secondary prevention interventions for cardiovascular disease
areappropriate.Menwithanaorticdiameterof25-29mmhave
an increased risk of cardiovascular disease, which disappears
when confounders such as smoking, deprivation, and
hypertension are taken into account. The Tromso study
compared participants with an aortic diameter of 27-29 mm
withareferencegroupmeasuring21-23mmandfoundatwofold
increase in cardiovascular mortality in the higher diameter
group.
15 In our study, the increased risk of mortality from all
causes for the 25-29 mm category became non-significant after
adjustment for confounding variables, perhaps reflecting the
differing diameter criteria used. However, there was a
significantly increased risk of subsequent hospital admission
due to hypertensive and ischaemic heart disease, heart failure,
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Itcouldbearguedthatinterventionsknowntoreducetheimpact
of these factors, such as smoking cessation, antihypertensive
treatment, statins, and aspirin, might reduce that risk.
Screeningforabdominalaorticaneurysmisbeingimplemented
throughouttheUnitedKingdom.Accordingtocurrentproposed
protocols, men with an aortic diameter less than 30 mm would
receive no further intervention and no follow-up screening. In
the Tromso study, it was recommended that those participants
with an aortic diameter greater than 27 mm should be followed
up for subsequent development of an aneurysm and for
cardiovascularriskreduction,althoughspecificsofafollow-up
regimen were not given.
15 Another study was even more
tentative, concluding that it remains unclear whether screening
for abdominal aortic aneurysm could be used to identify people
at risk of cardiovascular disease.
9
Strengths and weaknesses of the study
Our study has several strengths. The cohort comprised 86% of
men aged 65-74 in Highland and Western Isles at the time of
enrolment. We obtained outcome data by linking to national
hospital admissions and cancer and death registrations, with no
loss to follow-up. Data were available on a wide range of
potentialconfounders,includingsmoking,healthstatus,family
medicalhistory,andsocioeconomicstatus,enablingthesetobe
taken into account. An obvious limitation is that no women
were included in the cohort. Most screening programmes for
aortic aneurysm to date have not included women as they are
lesslikelytohaveaorticaneurysm
21andarelikelytohavethem
later in life than men.
22 Furthermore, although the cohort was
large, relatively few men died, so the study may have lacked
power to detect differences for some of the specific causes of
mortality.
Conclusions and policy implications
In conclusion, men can benefit from undergoing abdominal
aortic aneurysm screening. The problem that remains for men
with an enlarged, but non-aneurysmal aorta, is whether they
should be rescreened and whether they should be offered
interventions aimed at reducing their cardiovascular risk.
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RESEARCHWhat is already known on this topic
Screening for abdominal aortic aneurysm is effective in reducing aneurysm related mortality
Men with an aneurysm have a higher mortality from other vascular diseases than men without an aneurysm
What this study adds
Men with an ectatic aorta (25-29 mm) at time of screening for abdominal aortic aneurysm have a significantly higher risk of mortality
and of admission to hospital than men with a normal sized aorta (≤24 mm)
The increased risk of death was associated with higher rates of circulatory disease
The increased risk of admission to hospital was due to circulatory disease and chronic obstructive pulmonary disease
Tables
Table 1| Baseline personal and health related characteristics of all men by aortic diameter group. Values are numbers (percentages) of
participants unless stated otherwise
P value Total (n=8146)
Aortic diameter (mm)
Characteristic ≥30 (n=414) 25-29 (n=669) ≤24 (n=7063)
<0.001 70.3 (2.9) 70.8 (2.8) 70.6 (2.9) 70.3 (2.9) Mean (SD) age (years)
Place of birth:
0.760 864 (10.6) 50 (12.1) 69 (10.3) 745 (10.5) Western Isles
3431 (42.1) 179 (43.2) 295 (44.1) 2957 (41.9) Highland
2235 (27.4) 107 (25.8) 184 (27.5) 1944 (27.5) Rest of Scotland
1342 (16.5) 60 (14.5) 100 (14.9) 1182 (16.7) Rest of United Kingdom
219 (2.7) 12 (2.9) 15 (2.2) 192 (2.7) Other
55 (0.7) 6 (1.4) 6 (0.9) 43 (0.6) Missing
Years lived in Highland:
0.078 50 (26-69) 55 (27-70) 55 (27-70) 50 (26-69) Median (interquartile range)
258 (3.2) 14 (3.4) 23 (3.4) 221 (3.1) Missing
Deprivation fifth*:
0.183 250 (3.1) 5 (1.2) 24 (3.6) 221 (3.1) 1 (most deprived)
1908 (23.4) 105 (25.4) 153 (22.9) 1650 (23.4) 2
2948 (36.2) 147 (35.5) 269 (40.2) 2532 (35.8) 3
1775 (21.8) 94 (22.7) 138 (20.6) 1543 (21.8) 4
684 (8.4) 21 (5.1) 49 (7.3) 614 ( 8.7) 5 (least deprived)
581 (7.1) 42 (10.1) 36 (5.4) 503 (7.1) Missing
Urban-rural status†:
<0.001 1371 (16.8) 63 (15.2) 84 (12.6) 1224 (17.3) Other urban areas
1294 (15.9) 58 (14.0) 92 (13.8) 1144 (16.2) Accessible small towns and rural
1171 (14.4) 60 (14.5) 81 (12.1) 1030 (14.6) Remote small towns and rural
3737 (45.9) 191 (46.1) 377 (56.4) 3169 (44.9) Very remote small towns and rural
573 (7.0) 42 (10.1) 35 (5.2) 496 (7.0) Missing
Smoking status:
<0.001 2487 (30.5) 59 (14.3) 145 (21.7) 2283 (32.3) Never smoked
4142 (50.8) 224 (54.1) 356 (53.2) 3562 (50.4) Former smoker
1517 (18.6) 131 (31.6) 168 (25.1) 1218 (17.2) Current smoker
<0.001 25 (13-40) 36 (20-50) 30 (18-50) 24 (12-40) Median No (interquartile range) pack years‡
General health:
<0.001 1005 (12.3) 26 (6.3) 73 (10.9) 906 (12.8) Excellent
2949 (36.2) 136 (32.9) 218 (32.6) 2595 (36.7) Very good
2671 (32.8) 154 (37.2) 231 (34.5) 2286 (32.4) Good
1236 (15.2) 74 (17.9) 118 (17.6) 1044 (14.8) Fair
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P value Total (n=8146)
Aortic diameter (mm)
Characteristic ≥30 (n=414) 25-29 (n=669) ≤24 (n=7063)
223 (2.7) 18 (4.3) 21 (3.1) 184 (2.6) Poor
62 (0.8) 6 (1.4) 8 (1.2) 48 (0.7) Missing
<0.001 1132 (13.9) 88 (21.3) 117 (17.5) 927 (13.1) Ever had a heart attack
<0.001 3140 (38.5) 188 (45.4) 280 (41.9) 2672 (37.8) Ever had high blood pressure
<0.001 487 (6.0) 42 (10.1) 63 (9.4) 382 (5.4) Ever had a stroke
0.172 896 (11.0) 43 (10.4) 98 (14.6) 755 (10.7) Ever had diabetes
0.098 2086 (25.6) 121 (29.2) 174 (26.0) 1791 (25.4) Ever had a different condition
Close relative ever had a heart attack:
0.175 2686 (33.0) 138 (33.3) 242 (36.2) 2306 (32.6) Yes
5054 (62.0) 247 (59.7) 399 (59.6) 4408 (62.4) No
406 (5.0) 29 (7.0) 28 (4.2) 349 (4.9) Missing
Close relative ever had high blood pressure:
0.342 1791 (22.0) 95 (22.9) 153 (22.9) 1543 (21.8) Yes
5797 (71.2) 282 (68.1) 472 (70.6) 5043 (71.4) No
558 (6.8) 37 (8.9) 44 (6.6) 477 (6.8) Missing
Close relative ever had a stroke:
0.198 1577 (19.4) 67 (16.2) 132 (19.7) 1378 (19.5) Yes
6015 (73.8) 314 (75.8) 496 (74.1) 5205 (73.7) No
554 (6.8) 33 (8.0) 41 (6.1) 480 (6.8) Missing
Close relative ever had diabetes:
0.984 1025 (12.6) 45 (10.9) 98 (14.6) 882 (12.5) Yes
6509 (79.9) 333 (80.4) 530 (79.2) 5646 (79.9) No
612 (7.5) 36 (8.7) 41 (6.1) 535 (7.6) Missing
Close relative ever had an aortic aneurysm:
0.002 266 (3.3) 24 (5.8) 25 (3.7) 217 (3.1) Yes
7173 (88.1) 347 (83.8) 593 (88.6) 6233 (88.2) No
707 (8.7) 43 (10.4) 51 (7.6) 613 (8.7) Missing
*Based on Scottish index of multiple deprivation 2004.
†Based on Scottish Executive eightfold urban-rural classification.
‡Current and former smokers only.
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RESEARCHTable 2| Primary cause of death by aortic diameter group. Values are numbers (percentages) of participants unless stated otherwise
Adjusted hazard ratio* (99% CI) Crude hazard ratio (99% CI) Aortic diameter (mm)
Cause of death ≥30 (n=414) 25-29 (n=669) ≤24 (n=7063) ≥30 mm 25-29 mm ≥30 mm 25-29 mm
3.03 (1.41 to
6.53)
0.92 (0.33 to
2.57)
3.02 (1.50 to 6.06) 1.05 (0.43 to 2.59) 16 (3.9) 9 (1.3) 91 (1.3) Cancer
— — 1.71 (0.12 to
25.47)
1.06 (0.07 to
15.75)
1 (0.2) 1 (0.1) 10 (0.1) Diabetes
— — 0.95 (0.07 to
13.38)
1.17 (0.17 to 8.00) 1 (0.2) 2 (0.3) 18 (0.3) Central nervous system
disease
1.90 (1.17 to
3.08)
1.20 (0.75 to
1.94)
2.49 (1.63 to 3.78) 1.77 (1.20 to 2.63) 43 (10.4) 50 (7.5) 305 (4.3) Hypertensive and
vascular disease
— — — — 9 (2.2) 1 (0.1) 1 (<0.1) Aneurysm
0.53 (0.04 to
7.44)
1.04 (0.21 to
5.10)
1.06 (0.16 to 6.95) 0.99 (0.21 to 4.70) 2 (0.5) 3 (0.4) 32 (0.5) Chronic obstructive
pulmonary disease
— — — — 0 (0.0) 0 (0.0) 15 (0.2) Gastrointestinal
disease
— — — — 1 (0.2) 0 (0.0) 9 (0.1) Other external causes,
unintentional injuries,
and suicide
— — — — 0 (0.0) 3 (0.4) 31 (0.4) Other
2.03 (1.40 to
2.94)
1.08 (0.73 to
1.59)
2.57 (1.86 to 3.55) 1.46 (1.05 to 2.02) 73 (17.6) 69 (10.3) 512 (7.2) All causes
Group with aortic diameter ≤24 mm was reference category for both crude and adjusted hazard ratios.
*Adjusted for age; number of years lived in the Highlands; urban-rural status; number of pack years smoked; deprivation 10th; general health; ever had a heart
attack, high blood pressure, stroke, or different condition; and a close relative ever had an aortic aneurysm.
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RESEARCHTable 3| Risk of first admission to hospital for specific conditions by aortic diameter group. Values are numbers (percentages) of participants
unless stated otherwise
Adjusted hazard ratio* (99% CI) Crude hazard ratio (99% CI) Aortic diameter (mm)
Discharge
diagnosis ≥30 mm 25-29 mm ≥30 mm 25-29 mm ≥30 (n=414) 25-29 (n=669) ≤24 (n=7063)
1.51 (1.27 to 1.79)† 1.20 (1.04 to 1.39)† 1.92 (1.65 to 2.22)† 1.24 (1.09 to 1.42)† 329 (79.5) 406 (60.7) 3796 (53.7) All circulatory
disease:
1.60 (1.29 to 1.99)† 1.29 (1.08 to 1.54)† 2.10 (1.74 to 2.55)† 1.31 (1.11 to 1.54)† 198 (47.8) 270 (40.4) 2385 (33.8) Hypertensive
disease
1.66 (0.97 to 2.85) 1.43 (0.93 to 2.21) 2.91 (1.85 to 4.60)† 1.60 (1.07 to 2.37)† 35 (8.5) 48 (7.2) 363 (5.1) Acute myocardial
infarction
1.52 (1.18 to 1.94)† 1.33 (1.08 to 1.64)† 2.39 (1.93 to 2.96)† 1.41 (1.16 to 1.71)† 159 (38.4) 201 (30.0) 1633 (23.1) Ischaemic heart
disease
1.25 (0.78 to 2.01) 1.55 (1.12 to 2.14)† 2.40 (1.62 to 3.56)† 1.85 (1.39 to 2.46)† 46 (11.1) 95 (14.2) 587 (8.3) Heart failure
1.58 (1.02 to 2.45)† 1.35 (0.95 to 1.91) 2.58 (1.74 to 3.83)† 1.59 (1.16 to 2.18†) 46 (11.1) 76 (11.4) 559 (7.9) Cerebral vascular
disease
3.84 (1.39 to
10.63)†
1.56 (0.50 to 4.86) 6.55 (2.69 to
15.96)†
1.69 (0.60 to 4.77) 10 (2.4) 7 (1.0) 51 (0.7) Atherosclerosis
66.67 (41.59 to
106.88)†
6.75 (3.44 to
13.23)†
88.82 (58.14 to
135.70)†
7.92 (4.30 to
14.57)†
263 (63.5) 30 (4.5) 44 (0.6) Aneurysm
2.33 (1.49 to 3.62)† 1.33 (0.84 to 2.09) 4.67 (3.24 to 6.73)† 1.49 (0.99 to 2.27) 58 (14.0) 43 (6.4) 350 (5.0) Peripheral arterial
disease
1.21 (0.79 to 1.86) 1.46 (1.10 to 1.94)† 1.87 (1.28 to 2.72)† 1.55 (1.19 to 2.00)† 49 (11.8) 111 (16.6) 829 (11.7) Diabetes mellitus
1.38 (1.05 to 1.80)† 1.21 (0.98 to 1.51) 1.98 (1.57 to 2.50)† 1.33 (1.09 to 1.63)† 131 (31.6) 188 (28.1) 1630 (23.1) Diseases of the
respiratory system:
1.98 (1.37 to 2.86)† 1.47 (1.07 to 2.03)† 3.13(2.28 to 4.30)† 1.68 (1.25 to 2.24)† 73 (17.6) 90 (13.5) 623 (8.8) Chronic obstructive
pulmonary disease
7.81 (3.48 to
17.52)†
1.71 (0.60 to 4.88) 7.41 (3.63 to
15.15)†
2.14 (0.96 to 4.79) 16 (3.9) 12 (1.8) 69 (1.0) Abdominal wall and
peritoneal disease
1.32 (0.96 to 1.81) 1.17 (0.91 to 1.49) 1.71 (1.30 to 2.26)† 1.19 (0.95 to 1.48) 102 (24.6) 169 (25.3) 1736 (24.6) Neoplasms (all):
2.85 (1.50 to 5.40)† 1.29 (0.67 to 2.45) 3.92 (2.24 to 6.84)† 1.25 (0.67 to 2.32) 25 (6.0) 20 (3.0) 200 (2.8) Lung
1.83 (1.01 to 3.32)‡ 1.33 (0.82 to 2.16) 2.31 (1.38 to 3.85)† 1.32 (0.86 to 2.04) 27 (6.5) 42 (6.3) 399 (5.6) Digestive organs
and peritoneum
1.56 (0.63 to 3.84) 1.02 (0.50 to 2.11) 1.72 (0.78 to 3.81) 0.97 (0.51 to 1.86) 11 (2.7) 20 (3.0) 243 (3.4) Large bowel and
rectum
Group with aortic diameter ≤24 mm was reference category for both crude and adjusted hazard ratios.
*Adjusted for age; number of years lived in the Highlands; urban-rural status; number of pack years smoked; deprivation 10th; general health; ever had a heart
attack, high blood pressure, stroke, or different condition; and a close relative ever had an aortic aneurysm.
†P≤0.01.
‡P≤0.05.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e2958 doi: 10.1136/bmj.e2958 (Published 4 May 2012) Page 8 of 9
RESEARCHFigures
Fig 1 Time to hospital admission for all circulatory disease by aortic diameter
Fig 2 Time to hospital admission for aortic aneurysm by aortic diameter
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